The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 drugs for obesity in Medicare, called the BALANCE model, will not launch as scheduled on Jan
Research shows that GLP-1 medications such as semaglutide show promise for better kidney function, reduced inflammation throughout the body, and a healthier heart, says Kushner
Severe, persistent stomach pain needs urgent medical attention
The National Center for Biotechnology Information shared clinical supplement guidance explaining how berberine interacts with various metabolic enzymes and transporters
Studies suggest EMS can improve muscle tone, skin density, and overall facial rejuvenation (Shin et al., 2022)
To give you a bit of background Chubby Moms daughter (yes, me again ) actually got Exosome skin booster injections at a clinic three times before